Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

PURPOSE: The aim of our retrospective study was to determine the time to progression to castration-resistant prostate cancer (CRPC) in prostate cancer patients who undergo combined androgen blockade (CAB), as well as their prognoses. MATERIALS AND METHODS: We examined the overall survival (OS) and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamada, Satoshi, Iguchi, Taro, Kato, Minoru, Asakawa, Jumpei, Kita, Kazuaki, Yasuda, Sayaka, Yamasaki, Takeshi, Matsuoka, Yudai, Yamaguchi, Kazuyuki, Matsumura, Kentaro, Go, Ishun, Ohmachi, Tetsuji, Nakatani, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319345/
https://www.ncbi.nlm.nih.gov/pubmed/30651928
http://dx.doi.org/10.18632/oncotarget.26426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319345/
https://www.ncbi.nlm.nih.gov/pubmed/30651928
http://dx.doi.org/10.18632/oncotarget.26426

Ejemplares similares